CD8A and COVID-19: Sequencing was carried out on 10 000 FACS sorted activated CD8+ T cells from each donor, as well as on 10 000 FACS sorted nonactivated CD8+ T cells from 26 COVID-19 patients and all 10 previously SARS-CoV-2–exposed healthy controls.